相关实验视频

Updated: Jun 21, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

新诊断的质母细胞瘤的瘤治疗领域:一个回顾性分析

Chunyan Wang¹, Hao Xu², Yue Hu¹

¹Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Journal of neuro-oncology

|February 16, 2026

概括

瘤治疗场 (TTFields) 与Stupp疗法相结合,改善了质母细胞瘤 (GBM) 患者的生存结果. 更高的服从和长时间使用TTFields (超过2个月) 与更好的预后有关.

科学领域:

在瘤学瘤学.
生物医学工程生物医学工程
临床研究临床研究

背景情况:

瘤治疗场 (TTFields) 是一种新兴的非侵入性疗法,作为辅助癌症治疗,它显示出有前途.
目前,TTFields是标准质母细胞瘤 (GBM) 治疗的重要补充.
在GBM中对TTFields的现实数据对于优化临床实践至关重要.

研究的目的:

用临床数据评估TTFields在治疗GBM中的有效性.
探索影响TTFields在GBM患者中的疗效的临床因素.

主要方法:

对40名新诊断的GBM患者进行了回顾性队列研究,这些患者在Stupp疗程中接受TTFields.
选择了48名不接受TTFields的GBM患者的对照组.
卡普兰-梅尔曲线和考克斯回归分析被用来评估生存结果和预后因素.

主要成果:

与对照组相比,TTFields治疗显示出更高的无进展生存期 (PFS) 和总生存期 (OS) 的中位数.
切除的程度,MGMT促进物甲基化和TTFields疗法是PFS的独立预后因素.
较高的患者遵守 (≥0.81) 和长时间使用TTFields (>2个月) 与改善的OS和PFS显著相关.

结论:

TTFields与Stupp疗法相结合,改善了GBM患者的生存结果.
较高的患者服从性和长时间的TTFields使用与更好的预后有关.
这项研究提供了关于TTFields在GBM中的有效性的有价值的现实数据.

关键词:

质母细胞瘤 (glioblastoma) 是一个预测因素是一个预测因素.治疗瘤的领域.

更多相关视频

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields TTFields

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields TTFields

Published on: May 4, 2017

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.